BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35821557)

  • 21. Effect of KIT and PDGFRA Mutations on Survival in Patients With Gastrointestinal Stromal Tumors Treated With Adjuvant Imatinib: An Exploratory Analysis of a Randomized Clinical Trial.
    Joensuu H; Wardelmann E; Sihto H; Eriksson M; Sundby Hall K; Reichardt A; Hartmann JT; Pink D; Cameron S; Hohenberger P; Al-Batran SE; Schlemmer M; Bauer S; Nilsson B; Kallio R; Junnila J; Vehtari A; Reichardt P
    JAMA Oncol; 2017 May; 3(5):602-609. PubMed ID: 28334365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of immunohistochemical investigation of SDHB and molecular genetic analysis of SDH genes in the differential diagnosis of mesenchymal tumors of GIT.
    Dubova M; Sedivcova M; Michal M; Kokoskova B; Ryska A; Smid D; Daum O
    Histol Histopathol; 2015 Feb; 30(2):223-32. PubMed ID: 25205505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST.
    Pantaleo MA; Astolfi A; Urbini M; Nannini M; Paterini P; Indio V; Saponara M; Formica S; Ceccarelli C; Casadio R; Rossi G; Bertolini F; Santini D; Pirini MG; Fiorentino M; Basso U; Biasco G;
    Eur J Hum Genet; 2014 Jan; 22(1):32-9. PubMed ID: 23612575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imatinib in the management of multiple gastrointestinal stromal tumors associated with a germline KIT K642E mutation.
    Graham J; Debiec-Rychter M; Corless CL; Reid R; Davidson R; White JD
    Arch Pathol Lab Med; 2007 Sep; 131(9):1393-6. PubMed ID: 17824795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs).
    Lasota J; Miettinen M
    Semin Diagn Pathol; 2006 May; 23(2):91-102. PubMed ID: 17193822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple sporadic gastrointestinal stromal tumors (GISTs) of the proximal stomach are caused by different somatic KIT mutations suggesting a field effect.
    Agaimy A; Dirnhofer S; Wünsch PH; Terracciano LM; Tornillo L; Bihl MP
    Am J Surg Pathol; 2008 Oct; 32(10):1553-9. PubMed ID: 18724245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of succinate dehydrogenase subunit protein in succinate dehydrogenase-deficient gastrointestinal stromal tumors].
    Zhang YJ; Cheng YH; Guo LX; Wang NQ; Liu H
    Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):252-257. PubMed ID: 29690663
    [No Abstract]   [Full Text] [Related]  

  • 28. Succinate dehydrogenase deficient gastrointestinal stromal tumors (GISTs) - a review.
    Miettinen M; Lasota J
    Int J Biochem Cell Biol; 2014 Aug; 53():514-9. PubMed ID: 24886695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tyrosine-kinase mutations in c-KIT and PDGFR-alpha genes of imatinib naïve adult patients with gastrointestinal stromal tumours (GISTs) of the stomach and small intestine: relation to tumour-biological risk-profile and long-term outcome.
    Søreide K; Sandvik OM; Søreide JA; Gudlaugsson E; Mangseth K; Haugland HK
    Clin Transl Oncol; 2012 Aug; 14(8):619-29. PubMed ID: 22855146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric gastrointestinal stromal tumor: Report of two novel patients harboring germline variants in SDHB and SDHC genes.
    Rinelli M; Agolini E; Milano GM; Russo I; Crocoli A; De Vito R; Di Giannatale A; Di Paolo PL; Novelli A
    Cancer Genet; 2020 Feb; 241():61-65. PubMed ID: 31883676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial gastrointestinal stromal tumors, lentigines, and café-au-lait macules associated with germline c-kit mutation treated with imatinib.
    Gupta D; Chandrashekar L; Larizza L; Colombo EA; Fontana L; Gervasini C; Thappa DM; Rajappa M; Rajendiran KS; Sreenath GS; Kate V
    Int J Dermatol; 2017 Feb; 56(2):195-201. PubMed ID: 28074523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and epigenetic alterations of SDH genes in patients with sporadic succinate dehydrogenase-deficient gastrointestinal stromal tumors.
    Shi SS; Wang YF; Bao W; Ye SB; Wu N; Wang X; Xia QY; Li R; Shen Q; Zhou XJ
    Pathol Int; 2019 Jun; 69(6):350-359. PubMed ID: 31273876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Translational research and diagnosis in GIST].
    Wardelmann E
    Pathologe; 2012 Nov; 33 Suppl 2():273-7. PubMed ID: 22968735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Pediatric-type" gastrointestinal stromal tumors in adults: distinctive histology predicts genotype and clinical behavior.
    Rege TA; Wagner AJ; Corless CL; Heinrich MC; Hornick JL
    Am J Surg Pathol; 2011 Apr; 35(4):495-504. PubMed ID: 21358303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple gastrointestinal stromal tumors caused by a novel germline KIT gene mutation (Asp820Gly): a case report and literature review.
    Arima J; Hiramatsu M; Taniguchi K; Kobayashi T; Tsunematsu I; Kagota S; Sakane J; Suzuki Y; Hirota S
    Gastric Cancer; 2020 Jul; 23(4):760-764. PubMed ID: 32146645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SDHA loss-of-function mutations in KIT-PDGFRA wild-type gastrointestinal stromal tumors identified by massively parallel sequencing.
    Pantaleo MA; Astolfi A; Indio V; Moore R; Thiessen N; Heinrich MC; Gnocchi C; Santini D; Catena F; Formica S; Martelli PL; Casadio R; Pession A; Biasco G
    J Natl Cancer Inst; 2011 Jun; 103(12):983-7. PubMed ID: 21505157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel germline SDHB mutation in a gastrointestinal stromal tumor patient without bona fide features of the Carney-Stratakis dyad.
    Celestino R; Lima J; Faustino A; Máximo V; Gouveia A; Vinagre J; Soares P; Lopes JM
    Fam Cancer; 2012 Jun; 11(2):189-94. PubMed ID: 22160509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutational spectrum and classification of novel mutations in patients with metastatic gastrointestinal stromal tumours.
    Bombac A; Zakotnik B; Bucic M; Setrajcic Dragos V; Gazic B; Stegel V; Klancar G; Novakovic S
    Int J Oncol; 2020 Jun; 56(6):1468-1478. PubMed ID: 32236636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conventional Risk Stratification Fails to Predict Progression of Succinate Dehydrogenase-deficient Gastrointestinal Stromal Tumors: A Clinicopathologic Study of 76 Cases.
    Mason EF; Hornick JL
    Am J Surg Pathol; 2016 Dec; 40(12):1616-1621. PubMed ID: 27340750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types.
    Gill AJ; Chou A; Vilain R; Clarkson A; Lui M; Jin R; Tobias V; Samra J; Goldstein D; Smith C; Sioson L; Parker N; Smith RC; Sywak M; Sidhu SB; Wyatt JM; Robinson BG; Eckstein RP; Benn DE; Clifton-Bligh RJ
    Am J Surg Pathol; 2010 May; 34(5):636-44. PubMed ID: 20305538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.